Efficacy and Safety of Single Dose of 5 mg Zoledronic Acid in Chinese Patients With Paget's Disease of Bone (PDB)

This study is currently recruiting participants.

Study NCT00774020 Information provided by Novartis

First Received: October 15, 2008 Last Updated: May 27, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is currently recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	April 2010 (Final data collection date for primary outcome measure)